Sponsors

Screening for Cryptosporidium/Giardia by EIA

Cryptosporidiosis is routinely diagnosed by microscopic analysis of stool samples using organic dyes or by immunostaining by direct fluorescent antibody, and can be difficult to detect. Similarly, Giardia infection is frequently misdiagnosed, relying on poorly performing antigen-based testing.

Pro-Lab Diagnostics’ Prolisa Cryptosporidium/Giardia enzyme immunoassay (EIA) is a convenient, rapid and easy-to-use method for detecting Cryptosporidium and Giardia lamblia. Supplied in a 96-well test size consisting of detachable stripwells, this manual assay uses monoclonal anti-Cryptosporidium and anti-G. lamblia antibodies to ensure excellent sensitivity and specificity for high-value diagnostic results, and can also be performed on most automated platforms for increased workflow flexibility.

Mark Reed, General Manager of Pro-Lab Diagnostics, commented: “The Cryptosporidium/Giardia EIA is an important part of the Prolisa product range, offering our customers a simple and cost-effective alternative means of testing for cryptosporidiosis and giardiasis, with the back-up support of our team of application experts.”
www.pro-lab.com

Latest Issues

Introduction to bone marrow trephine

Online
9 December, 2025

Fresh muscle biopsies webinar

Online
11 December, 2025

POCT Innovators - The power to disrupt through diagnostics

National Army Museum, Chelsea, London
15 December, 2025

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026